UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Number of items: 347.


Aguilera, R; Saffie, C; Tittarelli, A; Gonzalez, FE; Ramirez, M; Reyes, D; ... Salazar-Onfray, F; + view all (2011) Heat-Shock Induction of Tumor-Derived Danger Signals Mediates Rapid Monocyte Differentiation into Clinically Effective Dendritic Cells. CLIN CANCER RES , 17 (8) 2474 - 2483. 10.1158/1078-0432.CCR-10-2384.

Aitchison, KL; Rahim, AA; Hughes, DA; Kinnon, C; Waddington, SN; Howe, SJ; (2011) Lentiviral vectors for gene therapy of Type I Gaucher Disease. HUM GENE THER , 22 (10) A44 - A44.

Allay, JA; Sleep, S; Long, S; Tillman, DM; Clark, R; Carney, G; ... Gray, JT; + view all (2011) Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial. HUM GENE THER , 22 (5) 595 - 604. 10.1089/hum.2010.202.

Amary, MF; Damato, S; Halai, D; Eskandarpour, M; Berisha, F; Bonar, F; ... Flanagan, AM; + view all (2011) Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet , 43 (12) 1262 - 1265. 10.1038/ng.994.

Anderson, K; Lutz, C; van Delft, FW; Bateman, CM; Guo, YP; Colman, SM; ... Greaves, M; + view all (2011) Genetic variegation of clonal architecture and propagating cells in leukaemia. NATURE , 469 (7330) 356 - +. 10.1038/nature09650.

Andrady, C; Sharma, SK; Chester, KA; (2011) Antibody-enzyme fusion proteins for cancer therapy. IMMUNOTHERAPY-UK , 3 (2) 193 - 211. 10.2217/IMT.10.90.

Anoop, P; Shaw, BE; Riley, U; Ethell, ME; Taj, M; Lancaster, DL; ... Potter, MN; + view all (2011) Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis. HEMATOLOGY , 16 (4) 213 - 220. 10.1179/102453311X13025568941763.

Arkenau, H-K; (2011) Capecitabine combined with oxaliplatin (CAPOX) in clinical practice: how significant is peripheral neuropathy? ANNALS OF ONCOLOGY , 22 (1) 239 - U282. 10.1093/annonc/mdq676.

Arkenau, HT; Kefford, R; Long, GV; (2011) Targeting BRAF for patients with melanoma. Br J Cancer , 104 (3) 392 - 398. 10.1038/sj.bjc.6606030.

Arkenau, HT; Nordman, I; Dobbins, T; Ward, R; (2011) Reporting time-to-event endpoints and response rates in 4 decades of randomized controlled trials in advanced colorectal cancer. Cancer , 117 (4) 832 - 840. 10.1002/cncr.25636.

Arthold, S; Kurowski, A; Wutz, A; (2011) Mechanistic insights into chromosome-wide silencing in X inactivation. Hum Genet , 130 (2) 295 - 305. 10.1007/s00439-011-1002-0.

Babu, B; Lee, M; Lee, L; Strobel, R; Brockway, O; Nickols, A; ... Lee, M; + view all (2011) Acetyl analogs of combretastatin A-4: Synthesis and biological studies. BIOORGAN MED CHEM , 19 (7) 2359 - 2367. 10.1016/j.bmc.2011.02.018.

Babu, B; Liu, Y; Plaunt, A; Riddering, C; Ogilvie, R; Westrate, L; ... Lee, M; + view all (2011) Design, synthesis and DNA binding properties of orthogonally positioned diamino containing polyamide f-IPI. BIOCHEM BIOPH RES CO , 404 (3) 848 - 852. 10.1016/j.bbrc.2010.12.073.

Bafadhel, M; McKenna, S; Terry, S; Mistry, V; Reid, C; Haldar, P; ... Brightling, CE; + view all (2011) Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med , 184 (6) 662 - 671. 10.1164/rccm.201104-0597OC.

Bakke, PS; Zhu, G; Gulsvik, A; Kong, X; Agusti, AG; Calverley, PM; ... Pillai, SG; + view all (2011) Candidate genes for COPD in two large data sets. Eur Respir J , 37 (2) 255 - 263. 10.1183/09031936.00091709.

Baraniskin, A; Munding, J; Schulmann, K; Meier, D; Porschen, R; Arkenau, HT; ... Reinacher-Schick, A; + view all (2011) Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy: a translational study of the AIO colorectal study group. Clin Colorectal Cancer , 10 (1) 24 - 29. 10.3816/CCC.2011.n.003.

Bates, AW; (2011) The anatomy of beauty in nineteenth-century England. Hektoen International , 3 (1)

Bell, CG; (2011) Integration of genomic and epigenomic DNA methylation data in common complex diseases by haplotype-specific methylation analysis. PERS MED , 8 (3) 243 - 251. 10.2217/PME.11.14.

Bennett, CL; Fallah-Arani, F; Conlan, T; Trouillet, C; Goold, H; Chorro, L; ... Chakraverty, R; + view all (2011) Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin. BLOOD , 117 (26) 7063 - 7069. 10.1182/blood-2011-01-329185.

Binny, C; McIntosh, J; Peruta, M; Kymalainen, H; Tuddenham, E; Waddington, S; ... Nathwani, A; + view all (2011) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous haemorrhage. HUMAN GENE THERAPY , 22 (10) A45 - A45.

Binny, C; McIntosh, J; Peruta, M; Kymalainen, H; Tuddenham, E; Waddington, S; ... Nathwani, A; + view all (2011) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous haemorrhage. HUMAN GENE THERAPY , 22 (10) A45 - A45.

Birkbak, NJ; Eklund, AC; Li, Q; McClelland, SE; Endesfelder, D; Tan, P; ... Swanton, C; + view all (2011) Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res , 71 (10) 3447 - 3452. 10.1158/0008-5472.CAN-10-3667.

Bolli, N; Payne, EM; Rhodes, J; Gjini, E; Johnston, AB; Guo, F; ... Look, AT; + view all (2011) cpsf1 is required for definitive HSC survival in zebrafish. Blood , 117 (15) 3996 - 4007. 10.1182/blood-2010-08-304030.

Boo, M; van Walraven, SM; Chapman, J; Lindberg, B; Schmidt, AH; Shaw, BE; ... World Marrow Donor Assoc,; + view all (2011) Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association. BLOOD , 117 (1) 21 - 25. 10.1182/blood-2010-07-298430.

Boshoff, C; (2011) Unraveling virus-induced lymphomagenesis. J CLIN INVEST , 121 (3) 838 - 841. 10.1172/JCI46499. Gold open access

Bramham, K; Hilton, R; Horsfield, C; McDonald, V; Camilleri, R; Hunt, BJ; (2011) ADAMTS-13 deficiency: can it cause chronic renal failure? Nephrol Dial Transplant , 26 (2) 742 - 744. 10.1093/ndt/gfq644.

Brehm, JM; Hagiwara, K; Tesfaigzi, Y; Bruse, S; Mariani, TJ; Bhattacharya, S; ... Celedón, JC; + view all (2011) Identification of FGF7 as a novel susceptibility locus for chronic obstructive pulmonary disease. Thorax , 66 (12) 1085 - 1090. 10.1136/thoraxjnl-2011-200017.

Briesemeister, D; Sommermeyer, D; Loddenkemper, C; Loew, R; Uckert, W; Blankenstein, T; Kammertoens, T; (2011) Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis. INT J CANCER , 128 (2) 371 - 378. 10.1002/ijc.25350.

Brough, R; Frankum, JR; Sims, D; Mackay, A; Mendes-Pereira, AM; Bajrami, I; ... Ashworth, A; + view all (2011) Functional viability profiles of breast cancer. Cancer Discov , 1 (3) 260 - 273. 10.1158/2159-8290.CD-11-0107.

Brucoli, F; Hawkins, RM; James, CH; Wells, G; Jenkins, TC; Ellis, T; ... Thurston, DE; + view all (2011) Novel C8-linked pyrrolobenzodiazepine (PBD)-heterocycle conjugates that recognize DNA sequences containing an inverted CCAAT box. BIOORG MED CHEM LETT , 21 (12) 3780 - 3783. 10.1016/j.bmcl.2011.04.054.

Brunetto, A; Olmos, D; Arkenau, HT; Tan, D; Yap, T; de Bono, J; ... Kaye, S; + view all (2011) Perceptions and referral trends into phase I oncology trials: results of a clinical survey. J Oncol , 2011 861401 - ?. 10.1155/2011/861401.

Calabretta, B; Salomoni, P; (2011) Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors. LEUKEMIA LYMPHOMA , 52 54 - 59. 10.3109/10428194.2010.546913.

Calleja-Agius, J; Muttukrishna, S; Pizzey, AR; Jauniaux, E; (2011) Pro- and antiinflammatory cytokines in threatened miscarriages. Am J Obstet Gynecol , 205 (1) 83.e8 - 83.16. 10.1016/j.ajog.2011.02.051.

Calvert, H; Azzariti, A; (2011) The clinical development of inhibitors of poly(ADP-ribose) polymerase. ANNALS OF ONCOLOGY , 22 i53 - i59. 10.1093/annonc/mdq667.

Cantu, C; Ierardi, R; Alborelli, I; Fugazza, C; Cassinelli, L; Piconese, S; ... Ronchi, A; + view all (2011) Sox6 enhances erythroid differentiation in human erythroid progenitors. BLOOD , 117 (13) 3669 - 3679. 10.1182/blood-2010-04-282350.

Cappellini, MD; Bejaoui, M; Agaoglu, L; Canatan, D; Capra, M; Cohen, A; ... Aydinok, Y; + view all (2011) Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. BLOOD , 118 (4) 884 - 893. 10.1182/blood-2010-11-316646.

Carpenter, L; Malladi, R; Yang, CT; French, A; Pilkington, KJ; Forsey, RW; ... Watt, SM; + view all (2011) Human induced pluripotent stem cells are capable of B-cell lymphopoiesis. BLOOD , 117 (15) 4008 - 4011. 10.1182/blood-2010-08-299941.

Casper, CJ; Warner, TT; Taanman, JW; Nathwani, AC; (2011) Generation of iPS-derived dopaminergic neurons as an in-vitro model of Rapid-Onset Dystonia Parkinsonism. HUMAN GENE THERAPY , 22 (10) A42 - A43.

Castaldi, PJ; Cho, MH; Litonjua, AA; Bakke, P; Gulsvik, A; Lomas, DA; ... COPDGene and Eclipse Investigators,; + view all (2011) The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility. Am J Respir Cell Mol Biol , 45 (6) 1147 - 1153. 10.1165/rcmb.2011-0055OC.

Castaldi, PJ; Demeo, DL; Hersh, CP; Lomas, DA; Soerheim, IC; Gulsvik, A; ... Silverman, EK; + view all (2011) Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax , 66 (10) 903 - 909. 10.1136/thx.2010.146118.

Catlin, SN; Busque, L; Gale, RE; Guttorp, P; Abkowitz, JL; (2011) The replication rate of human hematopoietic stem cells in vivo. BLOOD , 117 (17) 4460 - 4466. 10.1182/blood-2010-08-303537.

Cerone, MA; Burgess, DJ; Naceur-Lombardelli, C; Lord, CJ; Ashworth, A; (2011) High-throughput RNAi screening reveals novel regulators of telomerase. Cancer Res , 71 (9) 3328 - 3340. 10.1158/0008-5472.CAN-10-2734.

Chakraverty, R; Mackinnon, S; (2011) Allogeneic Transplantation for Lymphoma. J CLIN ONCOL , 29 (14) 1855 - 1863. 10.1200/JCO.2010.32.8419.

Chavda, S; Liu, Y; Babu, B; Davis, R; Sielaff, A; Ruprich, J; ... Lee, M; + view all (2011) Hx, a Novel Fluorescent, Minor Groove and Sequence Specific Recognition Element: Design, Synthesis, and DNA Binding Properties of p-Anisylbenzimidazole-imidazole/pyrrole-Containing Polyamides. BIOCHEMISTRY-US , 50 (15) 3127 - 3136. 10.1021/bi102028a.

Cheng, F; Pekkonen, P; Laurinavicius, S; Sugiyama, N; Henderson, S; Günther, T; ... Ojala, PM; + view all (2011) KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition. Cell Host Microbe , 10 (6) 577 - 590. 10.1016/j.chom.2011.10.011.

Chew, SK; Rad, R; Futreal, PA; Bradley, A; Liu, P; (2011) Genetic screens using the piggyBac transposon. Methods , 53 (4) 366 - 371. 10.1016/j.ymeth.2010.12.022.

Confer, DL; Shaw, BE; Pamphilon, DH; (2011) WMDA guidelines for subsequent donations following initial BM or PBSCs. Bone Marrow Transplantation , 46 (11) 1409 - 1412. 10.1038/bmt.2010.323.

Confer, DL; Shaw, BE; Pamphilon, DH; Clinical Working Grp WMDA,; (2011) WMDA guidelines for subsequent donations following initial BM or PBSCs. BONE MARROW TRANSPL , 46 (11) 1409 - 1412. 10.1038/bmt.2010.323.

Cornils, H; Kohler, RS; Hergovich, A; Hemmings, BA; (2011) Downstream of human NDR kinases Impacting on c-myc and p21 protein stability to control cell cycle progression. CELL CYCLE , 10 (12) 1897 - 1904. 10.4161/cc.10.12.15826.

Cornils, H; Kohler, RS; Hergovich, A; Hemmings, BA; (2011) Human NDR Kinases Control G(1)/S Cell Cycle Transition by Directly Regulating p21 Stability. MOL CELL BIOL , 31 (7) 1382 - 1395. 10.1128/MCB.01216-10.

Cortese, R; Lewin, J; Backdahl, L; Krispin, M; Wasserkort, R; Eckhardt, F; Beck, S; (2011) Genome-Wide Screen for Differential DNA Methylation Associated with Neural Cell Differentiation in Mouse. PLOS ONE , 6 (10) , Article e26002. 10.1371/journal.pone.0026002. Green and gold open access

Coward, J; Kulbe, H; Chakravarty, P; Leader, D; Vassileva, V; Leinster, DA; ... Balkwill, FR; + view all (2011) Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer. CLIN CANCER RES , 17 (18) 6083 - 6096. 10.1158/1078-0432.CCR-11-0945.

Cox, ST; Stephens, HA; Fernando, R; Karasu, A; Harber, M; Howie, AJ; ... Little, AM; + view all (2011) Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation. Hum Immunol , 72 (10) 827 - 834. 10.1016/j.humimm.2011.05.004.

Cuomo, ME; Platt, GM; Pearl, LH; Mittnacht, S; (2011) Cyclin-Cyclin-dependent Kinase Regulatory Response Is Linked to Substrate Recognition. J BIOL CHEM , 286 (11) 9713 - 9725. 10.1074/jbc.M110.173872. Gold open access

David, AL; McIntosh, J; Peebles, DM; Cook, T; Waddington, S; Weisz, B; ... Nathwani, AC; + view all (2011) Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep. HUM GENE THER , 22 (4) 419 - 426. 10.1089/hum.2010.007.

De Bono, JS; Logothetis, CJ; Molina, A; Fizazi, K; North, S; Chu, L; ... COU-AA-301 Investigators,; + view all (2011) Abiraterone and Increased Survival in Metastatic Prostate Cancer. NEW ENGL J MED , 364 (21) 1995 - 2005.

De Gobbi, M; Garrick, D; Lynch, M; Vernimmen, D; Hughes, JR; Goardon, N; ... Higgs, DR; + view all (2011) Generation of bivalent chromatin domains during cell fate decisions. EPIGENET CHROMATIN , 4 , Article 9. 10.1186/1756-8935-4-9. Gold open access

Dedes, KJ; Wetterskog, D; Ashworth, A; Kaye, SB; Reis-Filho, JS; (2011) Emerging therapeutic targets in endometrial cancer. Nat Rev Clin Oncol , 8 (5) 261 - 271. 10.1038/nrclinonc.2010.216.

Dedes, KJ; Wilkerson, PM; Wetterskog, D; Weigelt, B; Ashworth, A; Reis-Filho, JS; (2011) Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations. Cell Cycle , 10 (8) 1192 - 1199.

Della Peruta, M; Binny, C; Nathwani, D; Chokshi, S; McIntosh, J; Rosales, C; ... Nathwani, AC; + view all (2011) The development of a tumour-selective recombinant adeno-associated virus vector to target hepatocellular carcinoma. HUMAN GENE THERAPY , 22 (10) A113 - A113.

Denbo, JW; Williams, RF; Orr, WS; Sims, TL; Ng, CY; Zhou, JF; ... Davidoff, AM; + view all (2011) Continuous local delivery of interferon-beta stabilizes tumor vasculature in an orthotopic glioblastoma xenograft resection model. SURGERY , 150 (3) 497 - 504. 10.1016/j.surg.2011.07.044.

Dickens, JA; Lomas, DA; (2011) Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis. Drug Des Devel Ther , 5 391 - 405. 10.2147/DDDT.S14018.

Dickens, JA; Miller, BE; Edwards, LD; Silverman, EK; Lomas, DA; Tal-Singer, R; Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) study investigators,; (2011) COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res , 12 146 - ?. 10.1186/1465-9921-12-146.

Dina, R; Gudi, M; Kocjan, G; Schmitt, F; Vielh, P; (2011) Reply to: The danger to cytopathology of overspecialization and its relevance for histopathology Authors' response. CYTOPATHOLOGY , 22 (3) 209 - 210. 10.1111/j.1365-2303.2011.00875.x.

Dina, R; Gudi, M; Kocjan, G; Schmitt, F; Vielh, P; (2011) The danger to cytopathology of over-specialization and its relevance for histopathology. CYTOPATHOLOGY , 22 (2) 140 - 140. 10.1111/j.1365-2303.2011.00865.x.

Drew, Y; Ledermann, JA; Jones, A; Hall, G; Jayson, GC; Highley, M; ... Plummer, ER; + view all (2011) Phase II trial of the poly(ADP-ribose) polymerase (PARP) inhibitor AG-014699 in BRCA 1 and 2-mutated, advanced ovarian and/or locally advanced or metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY , 29 (15)

du Parcq, PA; Jones, P; Nelson, J; Miller, K; Diss, T; (2011) EGFR mutation in non-small cell lung cancer: one year of laboratory testing. LUNG CANCER , 71 S3 - S3.

Duarte, RF; Shaw, BE; Marin, P; Kottaridis, P; Ortiz, M; Morante, C; ... Russell, NH; + view all (2011) Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. BONE MARROW TRANSPL , 46 (1) 52 - 58. 10.1038/bmt.2010.54.

Dudderidge, TJ; Kelly, J; Wollenschlaeger, A; Leung, H; Okoturo, O; Prevost, T; ... Chromosomal Replicat Grp,; + view all (2011) DIAGNOSIS OF BLADDER CANCER BY COMBINED DETECTION OF MINICHROMOSOME MAINTENANCE 5 PROTEIN AND NMP22 IN URINE. EUR UROL SUPPL , 10 (2) 73 - 74.

Duvoix, A; Miranda, E; Perez, J; Sorensen, GL; Holmskov, U; Trapnell, BC; ... Lomas, DA; + view all (2011) Evaluation of full-length, cleaved and nitrosylated serum surfactant protein D as biomarkers for COPD. COPD , 8 (2) 79 - 95. 10.3109/15412555.2011.558542.

Ekeowa, UI; Marciniak, SJ; Lomas, DA; (2011) α(1)-antitrypsin deficiency and inflammation. Expert Rev Clin Immunol , 7 (2) 243 - 252. 10.1586/eci.10.95.

Elliott, P; Baker, R; Pasquale, F; Quarta, G; Ebrahim, H; Mehta, AB; ... ACES Study Grp,; + view all (2011) Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey. HEART , 97 (23) 1957 - 1960. 10.1136/heartjnl-2011-300364.

Evans, P; Cindrova-Davies, T; Muttukrishna, S; Burton, GJ; Porter, J; Jauniaux, E; (2011) Hepcidin and iron species distribution inside the first-trimester human gestational sac. MOL HUM REPROD , 17 (4) 227 - 232. 10.1093/molehr/gaq101.

Feber, A; Wilson, GA; Zhang, L; Presneau, N; Idowu, B; Down, TA; ... Beck, S; + view all (2011) Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors. Genome Research , 21 (4) pp. 515-524. 10.1101/gr.109678.110. Gold open access

Feber, A; Xi, LQ; Pennathur, A; Gooding, WE; Bandla, S; Wu, MX; ... Litle, VR; + view all (2011) MicroRNA Prognostic Signature for Nodal Metastases and Survival in Esophageal Adenocarcinoma. ANNALS OF THORACIC SURGERY , 91 (5) 1523 - 1530. 10.1016/j.athoracsur.2011.01.056.

Feng, G; Nadig, SN; Backdahl, L; Beck, S; Francis, RS; Schiopu, A; ... Bushell, A; + view all (2011) Functional Regulatory T Cells Produced by Inhibiting Cyclic Nucleotide Phosphodiesterase Type 3 Prevent Allograft Rejection. SCI TRANSL MED , 3 (83) , Article 83ra40. 10.1126/scitranslmed.3002099.

Feng, H; Hu, B; Liu, KW; Li, Y; Lu, X; Cheng, T; ... Cheng, SY; + view all (2011) Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans. J Clin Invest , 121 (12) 4670 - 4684. 10.1172/JCI58559.

Fenton, TR; Gout, IT; (2011) Functions and regulation of the 70 kDa ribosomal S6 kinases. INT J BIOCHEM CELL B , 43 (1) 47 - 59. 10.1016/j.bioce1.2010.09.018.

Fernandes, E; Goold, HD; Kissenpfennig, A; Malissen, B; Dyson, J; Bennett, CL; (2011) The Role of Direct Presentation by Donor Dendritic Cells in Rejection of Minor Histocompatibility Antigen-Mismatched Skin and Hematopoietic Cell Grafts. TRANSPLANTATION , 91 (2) 154 - 160. 10.1097/TP.0b013e318201ac27.

Fielding, AK; (2011) Current therapeutic strategies in adult acute lymphoblastic leukemia. Hematol Oncol Clin North Am , 25 (6) 1255 - viii. 10.1016/j.hoc.2011.09.008.

Fielding, AK; (2011) Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program , 2011 231 - 237. 10.1182/asheducation-2011.1.231.

Fielding, AK; (2011) Philadelphia-Positive Acute Lymphoblastic Leukemia-Is Bone Marrow Transplant Still Necessary? BIOL BLOOD MARROW TR , 17 (1) S84 - S88. 10.1016/j.bbmt.2010.11.023.

Flutter, B; Velica, P; Chakraverty, R; (2011) Memory lapses in graft-versus-host disease. EUR J IMMUNOL , 41 (9) 2530 - 2534. 10.1002/eji.201141946.

Foreman, MG; Kong, X; DeMeo, DL; Pillai, SG; Hersh, CP; Bakke, P; ... Silverman, EK; + view all (2011) Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol , 44 (3) 316 - 322. 10.1165/rcmb.2009-0360OC.

Forster, MD; Dedes, KJ; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; ... Molife, LR; + view all (2011) Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nat Rev Clin Oncol , 8 (5) 302 - 306. 10.1038/nrclinonc.2011.42.

Furuse, J; Okusaka, T; Bridgewater, J; Taketsuna, M; Wasan, H; Koshiji, M; Valle, J; (2011) Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer. Crit Rev Oncol Hematol , 80 (1) 31 - 39. 10.1016/j.critrevonc.2010.10.009.

Gal, A; Hughes, DA; Winchester, B; (2011) Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group. J INHERIT METAB DIS , 34 (2) 509 - 514. 10.1007/s10545-010-9261-9.

Gómez-López, S; Wiskow, O; Favaro, R; Nicolis, SK; Price, DJ; Pollard, SM; Smith, A; (2011) Sox2 and Pax6 maintain the proliferative and developmental potential of gliogenic neural stem cells In vitro. Glia , 59 (11) 1588 - 1599. 10.1002/glia.21201.

Goardon, N; Marchi, E; Atzberger, A; Quek, L; Schuh, A; Soneji, S; ... Vyas, P; + view all (2011) Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia. CANCER CELL , 19 (1) 138 - 152. 10.1016/j.ccr.2010.12.012.

Goldstein, R; Meyer, T; (2011) Role of everolimus in pancreatic neuroendocrine tumors. Expert Rev Anticancer Ther , 11 (11) 1653 - 1665. 10.1586/era.11.145.

Grabher, C; Payne, EM; Johnston, AB; Bolli, N; Lechman, E; Dick, JE; ... Look, AT; + view all (2011) Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb. Leukemia , 25 (3) 506 - 514. 10.1038/leu.2010.280.

Grimmett, C; Bridgewater, J; Steptoe, A; Wardle, J; (2011) Lifestyle and quality of life in colorectal cancer survivors. QUAL LIFE RES , 20 (8) 1237 - 1245. 10.1007/s11136-011-9855-1.

Gunaratnam, M; de la Fuente, M; Hampel, SM; Todd, AK; Reszka, AP; Schätzlein, A; Neidle, S; (2011) Targeting pancreatic cancer with a G-quadruplex ligand. Bioorg Med Chem , 19 (23) 7151 - 7157. 10.1016/j.bmc.2011.09.055.

Gutierrez, A; Grebliunaite, R; Feng, H; Kozakewich, E; Zhu, S; Guo, F; ... Look, AT; + view all (2011) Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med , 208 (8) 1595 - 1603. 10.1084/jem.20101691.

Hackshaw, A; Rodeck, C; Boniface, S; (2011) Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. HUM REPROD UPDATE , 17 (5) 589 - 604. 10.1093/humupd/dmr022. Gold open access

Harrison, P; Mackie, I; Mumford, A; Briggs, C; Liesner, R; Winter, M; ... British Comm Stand Haematology,; + view all (2011) Guidelines for the laboratory investigation of heritable disorders of platelet function. BRIT J HAEMATOL , 155 (1) 30 - 44. 10.1111/j.1365-2141.2011.08793.x.

Hart, DP; Skelton, S; Moss, DS; Sansom, CE; Gomez, K; Shepherd, AJ; (2011) Use of artificial neural networks for large scale prediction of factor VIII derived CD4 T cell epitopes. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 930 - 931.

Hartley, JA; (2011) The development of pyrrolobenzodiazepines as antitumour agents. EXPERT OPIN INV DRUG , 20 (6) 733 - 744. 10.1517/13543784.2011.573477.

Hartley, JM; Spanswick, VJ; Hartley, JA; (2011) Measurement of DNA damage in individual cells using the Single Cell Gel Electrophoresis (Comet) assay. Methods Mol Biol , 731 309 - 320. 10.1007/978-1-61779-080-5_25.

Haylock-Jacobs, S; Comerford, I; Bunting, M; Kara, E; Townley, S; Klingler-Hoffmann, M; ... McColl, SR; + view all (2011) PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. J Autoimmun , 36 (3-4) 278 - 287. 10.1016/j.jaut.2011.02.006.

Hergovich, A; (2011) MOB control: Reviewing a conserved family of kinase regulators. CELL SIGNAL , 23 (9) 1433 - 1440. 10.1016/j.cellsig.2011.04.007.

Hersh, CP; Silverman, EK; Gascon, J; Bhattacharya, S; Klanderman, BJ; Litonjua, AA; ... Mariani, TJ; + view all (2011) SOX5 is a candidate gene for chronic obstructive pulmonary disease susceptibility and is necessary for lung development. Am J Respir Crit Care Med , 183 (11) 1482 - 1489. 10.1164/rccm.201010-1751OC.

Herzog, RW; Davidoff, AM; Markusic, DM; Nathwani, AC; (2011) AAV Vector Biology in Primates: Finding the Missing Link? MOL THER , 19 (11) 1923 - 1924. 10.1038/mt.2011.218.

Hiwarkar, P; Shaw, BE; Tredger, JM; Brown, NW; Kulkarni, S; Saso, R; ... Potter, MN; + view all (2011) Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin. CLIN TRANSPLANT , 25 (2) 222 - 227. 10.1111/j.1399-0012.2010.01226.x.

Howie, AJ; (2011) Problems with 'focal segmental glomerulosclerosis'. Pediatr Nephrol , 26 (8) 1197 - 1205. 10.1007/s00467-010-1701-0.


Hughes, DA; Al-Sayed, M; Belmatoug, N; Bodamer, O; Bottcher, T; Cappellini, M; ... Weinreb, N; + view all (2011) Early access experience with VPRIV (R): Recommendations for 'core data' collection. BLOOD CELL MOL DIS , 47 (2) 140 - 142. 10.1016/j.bcmd.2010.10.015.

Hughes, DA; Romero, MAB; Hollak, CEM; Giugliani, R; Deegan, PB; FOS Investigators,; (2011) Response of women with Fabry disease to enzyme replacement therapy: Comparison with men, using data from FOS-the Fabry Outcome Survey. MOL GENET METAB , 103 (3) 207 - 214. 10.1016/j.ymgme.2011.03.022.

Ibrahim, M; Dodson, A; O'Grady, T; Parry, S; Miller, K; Doolan, C; Jasani, B; (2011) HER2 ICC Web-based interpretive scheme: a pilot study by the UK National External Quality Assessment Scheme for Immunocytochemistry and In Situ Hybridisation (UK NEQAS ICC & ISH). VIRCHOWS ARCH , 459 S73 - S74.

Ibrahim, M; Herriott, K; Parry, S; Miller, K; (2011) Audit of breast biomarkers markers, HER2.ER & PR in the UK: an update by the UK National External Quality Assessment Scheme for Immunocytochemistry and In Situ Hybridisation (UK NEQAS ICC & ISH). VIRCHOWS ARCH , 459 S74 - S74.

Ibrahim, M; Parry, S; Miller, K; (2011) Immunocytochemical staining of breast biomarkers HER2, ER and PR; potential pitfalls of false positive/negative staining: findings of the UK NEQAS ICC & ISH. VIRCHOWS ARCH , 459 S74 - S74.

Iorio, M; Piovan, C; Di Leva, G; Palmieri, D; Casalini, P; Braccioli, L; ... Tagliabue, E; + view all (2011) Breast cancer and microRNAs: Therapeutic impact. BREAST , 20 S6 - S6.

Jahn, TR; Kohlhoff, KJ; Scott, M; Tartaglia, GG; Lomas, DA; Dobson, CM; ... Crowther, DC; + view all (2011) Detection of early locomotor abnormalities in a Drosophila model of Alzheimer's disease. J Neurosci Methods , 197 (1) 186 - 189. 10.1016/j.jneumeth.2011.01.026.

Jennings, BH; (2011) Drosophila - a versatile model in biology & medicine. MATER TODAY , 14 (5) 190 - 195. Gold open access

Jiao, Y; Lawler, K; Patel, GS; Purushotham, A; Jones, AF; Grigoriadis, A; ... Teschendorff, AE; + view all (2011) DART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inference. BMC Bioinformatics , 12 403 - ?. 10.1186/1471-2105-12-403. Gold open access

Juergens, H; Daw, NC; Geoerger, B; Ferrari, S; Villarroel, M; Aerts, I; ... Gualberto, A; + view all (2011) Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma. J Clin Oncol , 29 (34) 4534 - 4540. 10.1200/JCO.2010.33.0670.

Kanga, U; McWhinnie, AJ; Mourya, M; Shaw, BE; Madrigal, JA; Mehra, NK; (2011) A novel HLA-DPB1 allele, DPB1*125:01, identified by sequence-based typing in an Indian individual. TISSUE ANTIGENS , 77 (1) 85 - 87. 10.1111/j.1399-0039.2010.01562.x.

Kasperavičiute, D; Catarino, CB; Chinthapalli, K; Clayton, LMS; Thom, M; Martinian, L; ... Sisodiya, SM; + view all (2011) Uncovering genomic causes of co-morbidity in epilepsy: Gene-driven phenotypic characterization of rare microdeletions. PLoS ONE , 6 (8) , Article e23182. 10.1371/journal.pone.0023182. Green and gold open access

Kato, H; Seto, K; Kobayashi, N; Yoshinaga, K; Meyer, T; Takei, M; (2011) CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. LIFE SCI , 89 (17-18) 603 - 608. 10.1016/j.lfs.2011.07.019.

Kautz-Neu, K; Noordegraaf, M; Dinges, S; Bennett, CL; John, D; Clausen, BE; von Stebut, E; (2011) Langerhans cells are negative regulators of the anti-leishmania response. Journal of Experimental Medicine , 208 (5) 885 - 91. 10.1084/jem.20102318.

Kepp, O; Galluzzi, L; Martins, I; Schlemmer, F; Adjemian, S; Michaud, M; ... Kroemer, G; + view all (2011) Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev , 30 (1) 61 - 69. 10.1007/s10555-011-9273-4.

Khwaja, A; (2011) PI3K as a Target for Therapy in Haematological Malignancies. CURR TOP MICROBIOL , 347 169 - 188. 10.1007/82_2010_71.

Kimata, Y; Kitamura, K; Fenner, N; Yamano, H; (2011) Mes1 controls the meiosis I to meiosis II transition by distinctly regulating the anaphase-promoting complex/cyclosome coactivators Fzr1/Mfr1 and Slp1 in fission yeast. MOL BIOL CELL , 22 (9) 1486 - 1494. 10.1091/mbc.E10-09-0774. Gold open access

King, RJ; Confer, DL; Greinix, HT; Halter, J; Horowitz, M; Schmidt, AH; ... Egeland, T; + view all (2011) Unrelated hematopoietic stem cell donors as research subjects. Bone Marrow Transplantation , 46 (1) 10 - 13. 10.1038/bmt.2010.37.

Kistler, AD; Siwy, J; Breunig, F; Jeevaratnam, P; Scherl, A; Mullen, W; ... Serra, AL; + view all (2011) A Distinct Urinary Biomarker Pattern Characteristic of Female Fabry Patients That Mirrors Response to Enzyme Replacement Therapy. PLOS ONE , 6 (6) , Article e20534. 10.1371/journal.pone.0020534. Green and gold open access

Kocjan, G; Chandra, A; Cross, PA; Giles, T; Johnson, SJ; Stephenson, TJ; ... Poller, DN; + view all (2011) The Interobserver Reproducibility of Thyroid Fine-Needle Aspiration Using the UK Royal College of Pathologists' Classification System. AM J CLIN PATHOL , 135 (6) 852 - 859. 10.1309/AJCPZ33MVMGZKEWU.

Kohlhoff, KJ; Jahn, TR; Lomas, DA; Dobson, CM; Crowther, DC; Vendruscolo, M; (2011) The iFly tracking system for an automated locomotor and behavioural analysis of Drosophila melanogaster. Integr Biol (Camb) , 3 (7) 755 - 760. 10.1039/c0ib00149j.

Kong, X; Cho, MH; Anderson, W; Coxson, HO; Muller, N; Washko, G; ... ECLIPSE Study NETT Investigators,; + view all (2011) Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. Am J Respir Crit Care Med , 183 (1) 43 - 49. 10.1164/rccm.201004-0541OC.

Kudsiova, L; Fridrich, B; Ho, J; Mustapa, MFM; Campbell, F; Welser, K; ... Lawrence, MJ; + view all (2011) Lipopolyplex Ternary Delivery Systems Incorporating C14 Glycerol-Based Lipids. MOL PHARMACEUT , 8 (5) 1831 - 1847. 10.1021/mp2001796.

Kudsiova, L; Ho, J; Fridrich, B; Harvey, R; Keppler, M; Ng, T; ... Lawrence, MJ; + view all (2011) Lipid chain geometry of C14 glycerol-based lipids: effect on lipoplex structure and transfection. MOL BIOSYST , 7 (2) 422 - 436. 10.1039/c0mb00149j.

Lawrenson, K; Sproul, D; Grun, B; Notaridou, M; Benjamin, E; Jacobs, IJ; ... Gayther, SA; + view all (2011) Modelling genetic and clinical heterogeneity in epithelial ovarian cancers. CARCINOGENESIS , 32 (10) 1540 - 1549. 10.1093/carcin/bgr140.

Lawrie, AS; Canciani, MT; Iseppi, J; Mackie, IJ; Machin, SJ; Peyvandi, F; (2011) High throughput detection of von Willebrand's disease using a new coagulation analyser. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 672 - 672.

Lawrie, AS; Mackie, IJ; Machin, SJ; Peyvandi, F; (2011) Evaluation of an automated platelet-based assay of ristocetin cofactor activity. HAEMOPHILIA , 17 (2) 252 - 256. 10.1111/j.1365-2516.2010.02419.x.

Ledermann, JA; (2011) Benefits of Enhancing the Platinum-Free Interval in the Treatment of Relapsed Ovarian Cancer More Than Just a Hypothesis? INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 21 S9 - S11. 10.1097/IGC.0b013e318217b30b.

Ledermann, JA; Hackshaw, A; Kaye, S; Jayson, G; Gabra, H; McNeish, I; ... Rustin, G; + view all (2011) Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer. J CLIN ONCOL , 29 (28) 3798 - 3804. 10.1200/JCO.2010.33.5208.

Ledermann, JA; Marth, C; Carey, MS; Birrer, M; Bowtell, DDL; Kaye, S; ... Gynecologic Canc InterGrp,; + view all (2011) Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer. INT J GYNECOL CANCER , 21 (4) 763 - 770. 10.1097/IGC.0b013e31821b2669.

Ledermann, JA; Raja, FA; (2011) Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer. Eur J Cancer , 47 Suppl 3 S104 - S115. 10.1016/S0959-8049(11)70154-X.

Lee, AJ; Endesfelder, D; Rowan, AJ; Walther, A; Birkbak, NJ; Futreal, PA; ... Swanton, C; + view all (2011) Chromosomal instability confers intrinsic multidrug resistance. Cancer Res , 71 (5) 1858 - 1870. 10.1158/0008-5472.CAN-10-3604.

Leoni, LM; Hartley, JA; (2011) Mechanism of Action: The Unique Pattern of Bendamustine-Induced Cytotoxicity. SEMIN HEMATOL , 48 (2) S12 - S23. 10.1053/j.seminhematol.2011.03.003.

Li, S-C; Chan, W-C; Lai, C-H; Tsai, K-W; Hsu, C-N; Jou, Y-S; ... Lin, W-C; + view all (2011) UMARS: Un-MAppable Reads Solution. BMC Bioinformatics , 12 (Suppl 1) S9 - S9. 10.1186/1471-2105-12-S1-S9. Gold open access

Li, S-C; Liao, Y-L; Chan, W-C; Ho, M-R; Tsai, K-W; Hu, L-Y; ... Lin, W-C; + view all (2011) Interrogation of rabbit miRNAs and their isomiRs. Genomics , 98 (6) 453 - 459. 10.1016/j.ygeno.2011.08.008.

Liccardi, G; Hartley, JA; Hochhauser, D; (2011) EGFR Nuclear Translocation Modulates DNA Repair following Cisplatin and Ionizing Radiation Treatment. CANCER RES , 71 (3) 1103 - 1114. 10.1158/0008-5472.CAN-10-2384. Gold open access

Linthorst, GE; Germain, DP; Hollak, CEM; Hughes, D; Rolfs, A; Wanner, C; Mehta, A; (2011) Expert opinion on temporary treatment recommendations for Fabry the disease during the shortage of enzyme replacement therapy (ERT). MOL GENET METAB , 102 (1) 99 - 102. 10.1016/j.ymgme.2010.11.155.

Lipman, PJ; Cho, MH; Bakke, P; Gulsvik, A; Kong, X; Lomas, DA; ... Lange, C; + view all (2011) On the follow-up of genome-wide association studies: an overall test for the most promising SNPs. Genet Epidemiol , 35 (5) 303 - 309. 10.1002/gepi.20578.

Liu, B; Moloney, A; Meehan, S; Morris, K; Thomas, SE; Serpell, LC; ... Crowther, DC; + view all (2011) Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J Biol Chem , 286 (6) 4248 - 4256. 10.1074/jbc.M110.158980.

Liu, H; Wang, W; Chew, SK; Lee, SC; Li, J; Vassiliou, GS; ... Liu, P; + view all (2011) Stella-Cre mice are highly efficient Cre deleters. Genesis , 49 (8) 689 - 695. 10.1002/dvg.20741.

Lobo, C; McQueen, A; Beale, T; Kocjan, G; (2011) The UK Royal College of Pathologists thyroid fine-needle aspiration diagnostic classification is a robust tool for the clinical management of abnormal thyroid nodules. Acta Cytol , 55 (6) 499 - 506. 10.1159/000333234.

Lolkema, MP; Arkenau, HT; Harrington, K; Roxburgh, P; Morrison, R; Roulstone, V; ... de Bono, JS; + view all (2011) A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer. Clin Cancer Res , 17 (3) 581 - 588. 10.1158/1078-0432.CCR-10-2159.

Lopez, MN; Pesce, B; Kurte, M; Perez, C; Segal, G; Roa, J; ... Salazar-Onfray, F; + view all (2011) A synthetic peptide homologous to IL-10 functional domain induces monocyte differentiation to TGF-beta plus tolerogenic dendritic cells. IMMUNOBIOLOGY , 216 (10) 1117 - 1126. 10.1016/j.imbio.2011.04.006.

Lotta, LA; Wu, HM; Mackie, IJ; Noris, M; Veyradier, A; Machin, SJ; ... Peyvandi, F; + view all (2011) Residual plasmatic activity of ADAMTS13 in congenital thrombotic thrombocytopenic purpura and its correlation with disease phenotype. J THROMB HAEMOST , 9 26 - 27.

Louis, CU; Savoldo, B; Dotti, G; Pule, M; Yvon, E; Myers, GD; ... Brenner, MK; + view all (2011) Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood , 118 (23) 6050 - 6056. 10.1182/blood-2011-05-354449.

Lowry, L; Smith, P; Qian, W; Falk, S; Benstead, K; Illidge, T; ... Hoskin, P; + view all (2011) Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol , 100 (1) 86 - 92. 10.1016/j.radonc.2011.05.013.

Mackie, I; Eapen, CE; Neil, D; Lawrie, AS; Chitolie, A; Shaw, JC; Elias, E; (2011) Idiopathic Noncirrhotic Intrahepatic Portal Hypertension is Associated with Sustained ADAMTS13 Deficiency. DIGEST DIS SCI , 56 (8) 2456 - 2465. 10.1007/s10620-011-1729-4.

Mackie, IJ; Langley, K; Chitolie, A; Leisner, R; Scully, M; Machin, S; Peyvandi, F; (2011) Discrepancies between different types of ADAMTS13 assays in patients with thrombotic microangiopathies. J THROMB HAEMOST , 9 210 - 210.

Mackinnon, S; Chakraverty, R; (2011) Families get mobilized to treat AML. BLOOD , 117 (3) 746 - 748. 10.1182/blood-2010-11-315929.

Mahadevan, D; Plummer, R; Squires, MS; Rensvold, D; Kurtin, S; Pretzinger, C; ... Calvert, H; + view all (2011) A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors. ANN ONCOL , 22 (9) 2137 - 2143. 10.1093/annonc/mdq734.

Manchanda, R; Abdelraheim, A; Johnson, M; Rosenthal, AN; Benjamin, E; Brunell, C; ... Menon, U; + view all (2011) Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG-INT J OBSTET GY , 118 (7) 814 - 824. 10.1111/j.1471-0528.2011.02920.x.

Mansour, MR; Look, AT; (2011) Discovery of a secreted tumor suppressor provides a promising therapeutic strategy for follicular lymphoma. Cancer Cell , 20 (5) 559 - 561. 10.1016/j.ccr.2011.10.027.

Martins, I; Kepp, O; Schlemmer, F; Adjemian, S; Tailler, M; Shen, S; ... Kroemer, G; + view all (2011) Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene , 30 (10) 1147 - 1158. 10.1038/onc.2010.500.

Mattar, CNZ; Nathwani, AC; Waddington, SN; Dighe, N; Kaeppel, C; Nowrouzi, A; ... Chan, JKY; + view all (2011) Stable Human FIX Expression After 0.9G Intrauterine Gene Transfer of Self-complementary Adeno-associated Viral Vector 5 and 8 in Macaques. MOL THER , 19 (11) 1950 - 1960. 10.1038/mt.2011.107.

Mattes, FM; Vargas, A; Kopycinski, J; Hainsworth, EG; Sweny, P; Nebbia, G; ... Emery, VC; + view all (2011) Erratum: Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation (American Journal of Transplantation (2008) 8 (990-999) DOI: 10.1111/j.1600-6143.2008.02191.x). American Journal of Transplantation , 11 (5) 1107 - 1107. 10.1111/j.1600-6143.2011.03549.x.

Maybin, JA; Battersby, S; Hirani, N; Nikitenko, LL; Critchley, HOD; Jabbour, HN; (2011) The Expression and Regulation of Adrenomedullin in the Human Endometrium: A Candidate for Endometrial Repair. ENDOCRINOLOGY , 152 (7) 2845 - 2856. 10.1210/en.2010-1256.

McDonald, V; Pizzey, A; Machin, SJ; Scully, MA; (2011) The development of acute idiopathic TTP is not associated with changes in T cell or T-regulatory cell numbers. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 915 - 916.

McIntosh, J; Lenting, P; Tuddenham, E; Nawathe, S; Waddington, S; Gray, J; ... Nathwani, A; + view all (2011) AAV mediated Factor VIII expression from a novel expression cassette with a potent codon-optimised FVIII construct. HUMAN GENE THERAPY , 22 (10) A28 - A28.

Melichar, B; Casado, E; Bridgewater, J; Bennouna, J; Campone, M; Vitek, P; ... Tabernero, J; + view all (2011) Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial. Br J Cancer , 105 (11) 1646 - 1653. 10.1038/bjc.2011.438.

Mellars, G; Gomez, K; (2011) Mutation detection by Southern blotting. Methods Mol Biol , 688 281 - 291. 10.1007/978-1-60761-947-5_19.

Mendoza-Naranjo, A; Bouma, G; Pereda, C; Ramirez, M; Webb, KF; Tittarelli, A; ... Salazar-Onfray, F; + view all (2011) Functional Gap Junctions Accumulate at the Immunological Synapse and Contribute to T Cell Activation. J IMMUNOL , 187 (6) 3121 - 3132. 10.4049/jimmunol.1100378.

Meyer, C; Sevko, A; Ramacher, M; Bazhin, AV; Falk, CS; Osen, W; ... Umansky, V; + view all (2011) Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proc Natl Acad Sci U S A , 108 (41) 17111 - 17116. 10.1073/pnas.1108121108.

Michaud, M; Martins, I; Sukkurwala, AQ; Adjemian, S; Ma, Y; Pellegatti, P; ... Kroemer, G; + view all (2011) Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science , 334 (6062) 1573 - 1577. 10.1126/science.1208347.

Mindell, J; Aresu, M; Zaninotto, P; Falaschetti, E; Poulter, N; (2011) Improving lipid profiles and increasing use of lipid-lowering therapy in England: results from a national cross-sectional survey-2006. Clinical Endocrinology , 75 (5) 621 - 627. 10.1111/j.1365-2265.2011.04094.x. Green open access

Mitchison, NA; Bhattacharya, S; Tuddenham, EGD; (2011) Human Congenital Diseases with Mixed Modes of Inheritance Have a Shortage of Recessive Disease. A Demographic Scenario? ANN HUM GENET , 75 688 - 693. 10.1111/j.1469-1809.2011.00679.x.

Mohammed, K; Dignan, F; Ethell, ME; Davies, FE; Morgan, GJ; Riley, U; ... Shaw, BE; + view all (2011) An early computed tomography-guided antifungal treatment strategy is safe and efficacious in patients undergoing chemotherapy for high-risk acute leukemia. LEUKEMIA LYMPHOMA , 52 (2) 339 - 340. 10.3109/10428194.2010.527407.

Morris, C; Cook, G; Streetly, M; Kettle, P; Drake, M; Quinn, M; ... Cavenagh, J; + view all (2011) Re-transplantation after bortezomib-based therapy. BRIT J HAEMATOL , 153 (5) 666 - 668. 10.1111/j.1365-2141.2010.08521.x.

Morris, CR; Kim, HY; Trachtenberg, F; Wood, J; Quinn, CT; Sweeters, N; ... Thalassemia Clinical Res Network,; + view all (2011) Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report. BLOOD , 118 (14) 3794 - 3802. 10.1182/blood-2010-11-319152.

Myers, RM; Stamatoyannopoulos, J; Snyder, M; Dunham, I; Hardison, RC; Bernstein, BE; ... Good, PJ; + view all (2011) A user's guide to the Encyclopedia of DNA elements (ENCODE). PLoS Biology , 9 (4) , Article e1001046. 10.1371/journal.pbio.1001046. Green and gold open access

Nathwani, A; Tuddenham, EGD; Rosales, C; Macintosh, J; Chowdary, P; Riddell, A; ... Davidoff, AM; + view all (2011) A Phase I/II clinical trial entailing peripheral vein administration of a novel self complementary adeno-associated viral vector encoding human FIX for Haemophilia B gene therapy. HUMAN GENE THERAPY , 22 (10) A20 - A20.

Nathwani, AC; Rosales, C; McIntosh, J; Rastegarlari, G; Nathwani, D; Raj, D; ... Davidoff, AM; + view all (2011) Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins. MOL THER , 19 (5) 876 - 885. 10.1038/mt.2010.274.

O'Mahony, C; Coats, C; Cardona, M; Garcia, A; Calcagnino, M; Murphy, E; ... Elliott, PM; + view all (2011) Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease. Europace , 13 (12) 1781 - 1788. 10.1093/europace/eur267.

Osawa, T; Davies, D; Hartley, JA; (2011) Mechanism of cell death resulting from DNA interstrand cross-linking in mammalian cells. CELL DEATH DIS , 2 , Article e187. 10.1038/cddis.2011.70. Gold open access

Pacey, S; Wilson, RH; Walton, M; Eatock, MM; Hardcastle, A; Zetterlund, A; ... Judson, I; + view all (2011) A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors. Clin Cancer Res , 17 (6) 1561 - 1570. 10.1158/1078-0432.CCR-10-1927.

Partridge, L; Alic, N; Bjedov, I; Piper, MDW; (2011) Ageing in Drosophila: The role of the insulin/Igf and TOR signalling network. Experimental Gerontology , 46 (5) 376 - 381. 10.1016/j.exger.2010.09.003. Green and gold open access

Patel, B; Dey, A; Ghorani, E; Kumar, S; Malam, Y; Rai, L; ... Fielding, AK; + view all (2011) Differential Cytopathology and Kinetics of Measles Oncolysis in Two Primary B-cell Malignancies Provides Mechanistic Insights. MOL THER , 19 (6) 1034 - 1040. 10.1038/mt.2011.44.

Paul, DS; Nisbet, JP; Yang, TP; Meacham, S; Rendon, A; Hautaviita, K; ... Deloukas, P; + view all (2011) Maps of open chromatin guide the functional follow-up of genome-wide association signals: application to hematological traits. PLoS Genet , 7 (6) , Article e1002139. 10.1371/journal.pgen.1002139. Green and gold open access

Payne, EM; Bolli, N; Rhodes, J; Abdel-Wahab, OI; Levine, R; Hedvat, CV; ... Look, AT; + view all (2011) Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML. Blood , 118 (4) 903 - 915. 10.1182/blood-2010-11-318022.

Peggs, KS; (2011) Chimeric antigen receptors: a costimulatory boost promotes immunological memory to B-cell malignancies. Expert Rev Anticancer Ther , 11 (11) 1667 - 1670. 10.1586/era.11.159.

Peggs, KS; Thomson, K; Samuel, E; Dyer, G; Armoogum, J; Chakraverty, R; ... Lowdell, MW; + view all (2011) Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation. CLIN INFECT DIS , 52 (1) 49 - 57. 10.1093/cid/ciq042.

Pennell, DJ; Porter, JB; Cappellini, MD; Chan, LL; El-Beshlawy, A; Aydinok, Y; ... Taher, A; + view all (2011) Continued improvement in myocardial T2(star) over two years of deferasirox therapy in beta-thalassemia major patients with cardiac iron overload. Haematologica - The Hematology Journal , 96 (1) 48 - 54. 10.3324/haematol.2010.031468. Green and gold open access

Perren, TJ; Swart, AM; Pfisterer, J; Ledermann, JA; Pujade-Lauraine, E; Kristensen, G; ... ICON7 Investigators,; + view all (2011) A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med , 365 (26) 2484 - 2496. 10.1056/NEJMoa1103799.

Pillay, N; Amary, FM; Berisha, F; Tirabosco, R; Flanagan, AM; (2011) P63 does not regulate brachyury expression in human chordomas and osteosarcomas. Histopathology , 59 (5) 1025 - 1027. 10.1111/j.1365-2559.2011.03973.x.

Plummer, R; Wilson, RH; Calvert, H; Boddy, AV; Griffin, M; Sludden, J; ... Nishiya, T; + view all (2011) A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours. BRIT J CANCER , 104 (4) 593 - 598. 10.1038/bjc.2011.6.

Porakishvili, N; Memon, A; Vispute, K; Kulikova, N; Clark, EA; Rai, KR; ... Lydyard, PM; + view all (2011) CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells. BRIT J HAEMATOL , 153 (4) 486 - 498. 10.1111/j.1365-2141.2011.08605.x.

Pors, K; Loadman, PM; Shnyder, SD; Sutherland, M; Sheldrake, HM; Guino, M; ... Patterson, LH; + view all (2011) Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity. CHEM COMMUN , 47 (44) 12062 - 12064. 10.1039/c1cc15638a.

Porter, JB; Evangeli, M; El-Beshlawy, A; (2011) Challenges of adherence and persistence with iron chelation therapy. Int J Hematol , 94 (5) 453 - 460. 10.1007/s12185-011-0927-3.

Porter, JB; Lin, KH; Beris, P; Forni, GL; Taher, A; Habr, D; ... EPIC Study Investigators,; + view all (2011) Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias. EUR J HAEMATOL , 87 (4) 338 - 348. 10.1111/j.1600-0609.2011.01660.x. Gold open access

Presneau, N; Shalaby, A; Ye, H; Pillay, N; Halai, D; Idowu, B; ... Flanagan, AM; + view all (2011) Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J Pathol , 223 (3) 327 - 335. 10.1002/path.2816.

Presneau, N; Shalaby, A; Ye, HT; Pillay, N; Halai, D; Idowu, B; ... Flanagan, AM; + view all (2011) Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J PATHOL , 223 (3) 327 - 335. 10.1002/path.2816.

Proctor, IE; McNamara, C; Rodriguez-Justo, M; Isaacson, PG; Ramsay, A; (2011) Importance of Expert Central Review in the Diagnosis of Lymphoid Malignancies in a Regional Cancer Network. J CLIN ONCOL , 29 (11) 1431 - 1435. 10.1200/JCO.2010.31.2223.

Puzanov, I; Lee, W; Chen, AP; Calcutt, MW; Hachey, DL; Vermeulen, WL; ... Rothenberg, ML; + view all (2011) Phase I Pharmacokinetic and Pharmacodynamic Study of SJG-136, a Novel DNA Sequence Selective Minor Groove Cross-linking Agent, in Advanced Solid Tumors. CLIN CANCER RES , 17 (11) 3794 - 3802. 10.1158/1078-0432.CCR-10-2056.

Qiu, W; Cho, MH; Riley, JH; Anderson, WH; Singh, D; Bakke, P; ... ECLIPSE Investigators,; + view all (2011) Genetics of sputum gene expression in chronic obstructive pulmonary disease. PLoS One , 6 (9) , Article e24395 . 10.1371/journal.pone.0024395. Green and gold open access

Quezada, SA; Peggs, KS; (2011) Tumor-reactive CD4(+) T cells: plasticity beyond helper and regulatory activities. IMMUNOTHERAPY-UK , 3 (8) 915 - 917. 10.2217/IMT.11.83.

Quezada, SA; Peggs, KS; Simpson, TR; Allison, JP; (2011) Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. IMMUNOL REV , 241 104 - 118. 10.1111/j.1600-065X.2011.01007.x.

Raj, D; Davidoff, AM; Nathwani, AC; (2011) Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challenges. EXPERT REV HEMATOL , 4 (5) 539 - 549. 10.1586/EHM.11.48.

Raja, FA; Griffin, CL; Qian, W; Hirte, H; Parmar, MK; Swart, AM; Ledermann, JA; (2011) Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer. BRIT J CANCER , 105 (7) 884 - 889. 10.1038/bjc.2011.334.

Rakyan, VK; Beyan, H; Down, TA; Hawa, MI; Maslau, S; Aden, D; ... Leslie, RD; + view all (2011) Identification of Type 1 Diabetes-Associated DNA Methylation Variable Positions That Precede Disease Diagnosis. PLOS GENET , 7 (9) , Article e1002300. 10.1371/journal.pgen.1002300. Green and gold open access

Rakyan, VK; Down, TA; Balding, DJ; Beck, S; (2011) Epigenome-wide association studies for common human diseases. NAT REV GENET , 12 (8) 529 - 541. 10.1038/nrg3000.

Ran, Y; Ethaar, E-E; Vineeth, R; Mathew, R; Barbara, PR; Erik, A; (2011) One-pot Formation of a I-125-labeled Trifunctional Reagent for Multiscale Imaging with Optical and Nuclear Techniques. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS , 54 S57 - S57.

Rashid, ST; Yusa, K; Strick-Marchand, H; Lomas, DA; Bradly, A; Vallier, L; (2011) Human induced pluripotent stem cells for cell therapy against Inherited Metabolic disorders. HUMAN GENE THERAPY , 22 (10) A9 - A10.

Reid, JM; Buhrow, SA; Kuffel, MJ; Jia, L; Spanswick, VJ; Hartley, JA; ... Ames, MM; + view all (2011) Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in rats. CANCER CHEMOTH PHARM , 68 (3) 777 - 786. 10.1007/s00280-010-1517-4.

Richardson, SE; McNamara, C; (2011) The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future. Adv Hematol , 2011 865870 - ?. 10.1155/2011/865870.

Ringwald, M; Iyer, V; Mason, JC; Stone, KR; Tadepally, HD; Kadin, JA; ... Skarnes, WC; + view all (2011) The IKMC web portal: a central point of entry to data and resources from the International Knockout Mouse Consortium. NUCLEIC ACIDS RES , 39 D849 - D855. 10.1093/nar/gkq879. Gold open access

Rodríguez-González, R; Millán, M; Sobrino, T; Miranda, E; Brea, D; de la Ossa, NP; ... Castillo, J; + view all (2011) The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome. Thromb Haemost , 105 (3) 421 - 429. 10.1160/TH10-09-0621.

Rodríguez-González, R; Sobrino, T; Rodríguez-Yáñez, M; Millán, M; Brea, D; Miranda, E; ... Castillo, J; + view all (2011) Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke. J Transl Med , 9 58 - ?. 10.1186/1479-5876-9-58.

Rosales, C; McIntosh, J; Hanley, J; Nathwani, A; Morton, C; Davidoff, A; (2011) A novel epigenetic modifier significantly improves recombinant adeno-associated virus vector mediated transgene expression in mice. HUMAN GENE THERAPY , 22 (10) A107 - A107.

Rustin, G; Reed, N; Jayson, GC; Ledermann, JA; Adams, M; Perren, T; ... Kaye, S; + view all (2011) A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer. ANN ONCOL , 22 (11) 2411 - 2416. 10.1093/annonc/mdq780.

Sabry, M; Tsirogianni, M; Bakhsh, IA; North, J; Sivakumaran, J; Giannopoulos, K; ... Lowdell, MW; + view all (2011) Leukemic priming of resting NK cells is killer Ig-like receptor independent but requires CD15-mediated CD2 ligation and natural cytotoxicity receptors. J Immunol , 187 (12) 6227 - 6234. 10.4049/jimmunol.1101640.

Salazar, R; Plummer, R; Oaknin, A; Robinson, A; Pardo, B; Soto-Matos, A; ... Calvert, AH; + view all (2011) Phase I study of weekly plitidepsin as 1-hour infusion combined with carboplatin in patients with advanced solid tumors or lymphomas. INVEST NEW DRUG , 29 (6) 1406 - 1413. 10.1007/s10637-010-9488-1.

Salomoni, P; (2011) KAPping PML nuclear body number. CELL CYCLE , 10 (5) 735 - 736. 10.4161/cc.10.5.14927.

Salomoni, P; Betts-Henderson, J; (2011) The Role of PML in the Nervous System. MOL NEUROBIOL , 43 (2) 114 - 123. 10.1007/s12035-010-8156-y.

Saravanan, K; Barlow, HC; Barton, M; Calvert, AH; Golding, BT; Newell, DR; ... Griffin, RJ; + view all (2011) Nucleoside Transport Inhibitors: Structure-Activity Relationships for Pyrimido[5,4-d]pyrimidine Derivatives That Potentiate Pemetrexed Cytotoxicity in the Presence of alpha(1)-Acid Glycoprotein. J MED CHEM , 54 (6) 1847 - 1859. 10.1021/jm101493z.

Screaton, NJ; Miller, FN; Patel, BD; Groves, A; Tasker, AD; Lomas, DA; Flower, CD; (2011) The clinical impact of high resolution computed tomography in patients with respiratory disease. Eur Radiol , 21 (2) 225 - 231. 10.1007/s00330-010-1923-3.

Serrano, AE; Menares-Castillo, E; Garrido-Tapia, M; Ribeiro, CH; Hernandez, CJ; Mendoza-Naranjo, A; ... Molina, MC; + view all (2011) Interleukin 10 decreases MICA expression on melanoma cell surface. IMMUNOL CELL BIOL , 89 (3) 447 - 457. 10.1038/icb.2010.100.

Shalaby, A; Presneau, N; Ye, H; Halai, D; Berisha, F; Idowu, B; ... Flanagan, AM; + view all (2011) The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target. J Pathol , 223 (3) 336 - 346. 10.1002/path.2818.

Shaw, BE; Apperley, JF; Russell, NH; Craddock, C; Liakopoulou, E; Potter, MN; ... Byrne, JL; + view all (2011) Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease. BRIT J HAEMATOL , 153 (2) 244 - 252. 10.1111/j.1365-2141.2011.08615.x.

Shaw, BE; Confer, DL; Hwang, WY; Pamphilon, DH; Pulsipher, MA; (2011) Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association. HAEMATOL-HEMATOL J , 96 (7) 942 - 947. 10.3324/haematol.2011.045740. Gold open access

Shiltagh, N; Hansen, FD; Gomez, K; Perkins, SJ; Tuddenham, EGD; (2011) Reassignment of the modular architecture of von Willebrand factor: novel structural insights into the non-a repeat region revealing the major FVIII binding region. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 661 - 662.

Shimazu, S; Nagamura, Y; Yaguchi, H; Ohkura, N; Tsukada, T; (2011) Correlation of mutant menin stability with clinical expression of multiple endocrine neoplasia type 1 and its incomplete forms. Cancer Sci , 102 (11) 2097 - 2102. 10.1111/j.1349-7006.2011.02055.x.

Siddiqui, GK; Maclean, AB; Elmasry, K; Fong, AWT; Morris, RW; Rashid, M; ... Boxer, GM; + view all (2011) Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer. ANGIOGENESIS , 14 (2) 155 - 161. 10.1007/s10456-010-9199-4.

Siddle, HV; Deakin, JE; Coggill, P; Whilming, L; Harrow, J; Kaufman, J; ... Belov, K; + view all (2011) The tammar wallaby major histocompatibility complex shows evidence of past genomic instability. BMC GENOMICS , 12 , Article 421. 10.1186/1471-2164-12-421. Green and gold open access

Siedlinski, M; Cho, MH; Bakke, P; Gulsvik, A; Lomas, DA; Anderson, W; ... ECLIPSE Investigators,; + view all (2011) Genome-wide association study of smoking behaviours in patients with COPD. Thorax , 66 (10) 894 - 902. 10.1136/thoraxjnl-2011-200154.

Silverman, EK; Vestbo, J; Agusti, A; Anderson, W; Bakke, PS; Barnes, KC; ... Crapo, JD; + view all (2011) Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report. COPD , 8 (2) 121 - 135. 10.3109/15412555.2011.558864.

Sims, D; Mendes-Pereira, AM; Frankum, J; Burgess, D; Cerone, MA; Lombardelli, C; ... Lord, CJ; + view all (2011) High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing. Genome Biol , 12 (10) R104 - ?. 10.1186/gb-2011-12-10-r104.

Sin, DD; Miller, BE; Duvoix, A; Man, SF; Zhang, X; Silverman, EK; ... ECLIPSE Investigators,; + view all (2011) Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med , 183 (9) 1187 - 1192. 10.1164/rccm.201008-1220OC.

Sivabalasingham, S; Fersht, N; D'Souza, D; Rosenberg, I; Stacey, C; Davies, P; ... Short, S; + view all (2011) Preliminary Results from a Phase I/II Study of Intensity Modulated Radiotherapy in the Treatment of Meningiomas. CLIN ONCOL-UK , 23 (3) S53 - S53.

Smith, SW; Eardley, KS; Croft, AP; Nwosu, J; Howie, AJ; Cockwell, P; ... Savage, CO; + view all (2011) CD248+ stromal cells are associated with progressive chronic kidney disease. Kidney Int , 80 (2) 199 - 207. 10.1038/ki.2011.103.

Sobota, A; Yamashita, R; Xu, Y; Trachtenberg, F; Kohlbry, P; Kleinert, DA; ... Thalassemia Clinical Res Network,; + view all (2011) Quality of life in Thalassemia: A comparison of SF-36 results from the Thalassemia longitudinal cohort to reported literature and the US norms. AM J HEMATOL , 86 (1) 92 - 95. 10.1002/ajh.21896.

Sofueva, S; Osman, F; Lorenz, A; Steinacher, R; Castagnetti, S; Ledesma, J; Whitby, MC; (2011) Ultrafine anaphase bridges, broken DNA and illegitimate recombination induced by a replication fork barrier. Nucleic Acids Research , 39 (15) 6568- 6584. 10.1093/nar/gkr340. Green and gold open access

Spencer, J; Amin, J; Coxhead, P; McGeehan, J; Richards, CJ; Tizzard, GJ; ... Guille, M; + view all (2011) Size Does Matter. Sterically Demanding Metallocene-Substituted 3-Methylidene-Oxindoles Exhibit Poor Kinase Inhibitory Action. ORGANOMETALLICS , 30 (11) 3177 - 3181. 10.1021/om200278j.

Starke, RD; Ferraro, F; Paschalaki, KE; Dryden, NH; McKinnon, TAJ; Sutton, RE; ... Randi, AM; + view all (2011) Endothelial von Willebrand factor regulates angiogenesis. BLOOD , 117 (3) 1071 - 1080. 10.1182/blood-2010-01-264507.

Starke, RD; Paschalaki, KE; Ferraro, F; Dryden, NH; McKinnon, TAJ; Sutton, RE; ... Randi, AM; + view all (2011) BLOOD-DERIVED ENDOTHELIAL PROGENITOR CELLS FROM VON WILLEBRAND'S DISEASE PATIENTS DEMONSTRATE THAT VON WILLEBRAND FACTOR REGULATES ANGIOGENESIS. HEART , 97 (20) 14 - 14. 10.1136/heartjnl-2011-300920b.39.

Stephens, PJ; Greenman, CD; Fu, BY; Yang, FT; Bignell, GR; Mudie, LJ; ... Campbell, PJ; + view all (2011) Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development. CELL , 144 (1) 27 - 40. 10.1016/j.cell.2010.11.055.

Strenger, V; Pfurtscheller, K; Wendelin, G; Aberle, SW; Nacheva, EP; Zohrer, B; ... Popow-Kraupp, T; + view all (2011) Differentiating Inherited Human Herpesvirus Type 6 Genome from Primary Human Herpesvirus Type 6 Infection by Means of Dried Blood Spot from the Newborn Screening Card. J PEDIATR-US , 159 (5) 859 - 861. 10.1016/j.jpeds.2011.06.032.

Strenger, V; Urban, C; Schwinger, W; Nacheva, EP; Aberle, SW; (2011) Transmission of Chromosomally Integrated HHV-6 by Bone Marrow Transplantation. PEDIATR BLOOD CANCER , 56 (1) 171 - 171. 10.1002/pbc.22828.

Stuart, GC; Kitchener, H; Bacon, M; duBois, A; Friedlander, M; Ledermann, J; ... Gynecologic Cancer Intergroup,; + view all (2011) 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference. Int J Gynecol Cancer , 21 (4) 750 - 755. 10.1097/IGC.0b013e31821b2568.

Sun, Y; Hu, J; Zhou, L; Pollard, SM; Smith, A; (2011) Interplay between FGF2 and BMP controls the self-renewal, dormancy and differentiation of rat neural stem cells. J Cell Sci , 124 (Pt 11) 1867 - 1877. 10.1242/jcs.085506.

Surinova, S; Schiess, R; Hüttenhain, R; Cerciello, F; Wollscheid, B; Aebersold, R; (2011) On the development of plasma protein biomarkers. J Proteome Res , 10 (1) 5 - 16. 10.1021/pr1008515.

Swerdlow, AJ; Higgins, CD; Smith, P; Cunningham, D; Hancock, BW; Horwich, A; ... Linch, DC; + view all (2011) Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study. J CLIN ONCOL , 29 (31) 4096 - 4104. 10.1200/JCO.2011.34.8268.

Taner, SB; Pando, MJ; Roberts, A; Schellekens, J; Marsh, SG; Malmberg, KJ; ... Brodsky, FM; + view all (2011) Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention. J Immunol , 186 (1) 62 - 72. 10.4049/jimmunol.0903657.

Taveirne, S; De Colvenaer, V; Van Den Broeck, T; Van Ammel, E; Bennett, CL; Taghon, T; ... Leclercq, G; + view all (2011) Langerhans cells are not required for epidermal V gamma 3 T cell homeostasis and function. J LEUKOCYTE BIOL , 90 (1) 61 - 68. 10.1189/jlb.1010581.

Taylor, RM; Grieve, A; Gibson, F; Dhawan, A; Franck, LS; (2011) Parental assessment of adolescent quality of life: can it replace self-assessment? Qual Life Res , 20 (10) 1715 - 1720. 10.1007/s11136-011-9904-9.

Teschendorff, AE; Zhuang, J; Widschwendter, M; (2011) Independent surrogate variable analysis to deconvolve confounding factors in large-scale microarray profiling studies. BIOINFORMATICS , 27 (11) 1496 - 1505. 10.1093/bioinformatics/btr171.

Thephinlap, C; Phisalaphong, C; Lailerd, N; Chattipakorn, N; Winichagoon, P; Vadolus, J; ... Srichairatanakool, S; + view all (2011) Reversal of Cardiac Iron Loading and Dysfunction in Thalassemic Mice by Curcuminoids. MED CHEM , 7 (1) 62 - 69.

Thirlwell, C; Schulz, L; Dibra, H; Beck, S; (2011) Suffocating cancer: hypoxia-associated epimutations as targets for cancer therapy. Clin Epigenetics , 3 9 - ?. 10.1186/1868-7083-3-9.

Thomas, MR; Machin, SJ; Mackie, I; Scully, MA; (2011) B cell activating factor is elevated in acute idiopathic thrombotic thrombocytopenic purpura. Br J Haematol , 155 (5) 620 - 622. 10.1111/j.1365-2141.2011.08730.x.

Thomson, KJ; Mackinnon, S; (2011) T-Cell-Depleted Reduced-Intensity Conditioning Transplantation for Lymphoma: Do Donor Lymphocyte Infusions Really Matter? Reply. J CLIN ONCOL , 29 (9) E244 - E244. 10.1200/JCO.2010.33.1207.

Trachtenberg, F; Vichinsky, E; Haines, D; Pakbaz, Z; Mednick, L; Sobota, A; ... Thalassemia Clinical Res Network,; + view all (2011) Iron Chelation Adherence to Deferoxamine and Deferasirox in Thalassemia. AM J HEMATOL , 86 (5) 433 - 436. 10.1002/ajh.21993.

Tsai, K-W; Liao, Y-L; Wu, C-W; Hu, L-Y; Li, S-C; Chan, W-C; ... Lin, W-C; + view all (2011) Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics , 6 (10) 1189 - 1197. 10.4161/epi.6.10.16535.

Tsai, K-W; Wu, C-W; Hu, L-Y; Li, S-C; Liao, Y-L; Lai, C-H; ... Lin, W-C; + view all (2011) Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. International Journal of Cancer , 129 (11) 2600 - 2610. 10.1002/ijc.25919.

van Zyl-Smit, RN; Binder, A; Meldau, R; Mishra, H; Semple, PL; Theron, G; ... Dheda, K; + view all (2011) Comparison of Quantitative Techniques including Xpert MTB/RIF to Evaluate Mycobacterial Burden. PLOS ONE , 6 (12) , Article e28815. 10.1371/journal.pone.0028815. Green and gold open access

Vaughan, S; Coward, JI; Bast, RC; Berchuck, A; Berek, JS; Brenton, JD; ... Balkwill, FR; + view all (2011) Rethinking ovarian cancer: recommendations for improving outcomes. NAT REV CANCER , 11 (10) 719 - 725. 10.1038/nrc3144.

Vazquez, I; Bridgewater, J; (2011) Nonsurgical therapy of biliary tract cancer. Curr Opin Gastroenterol , 27 (3) 258 - 261. 10.1097/MOG.0b013e3283454f09.

Velica, P; Bunce, CM; (2011) A QUICK, SIMPLE AND UNBIASED METHOD TO QUANTIFY C2C12 MYOGENIC DIFFERENTIATION. MUSCLE NERVE , 44 (3) 366 - 370. 10.1002/mus.22056.

Vestbo, J; Edwards, LD; Scanlon, PD; Yates, JC; Agusti, A; Bakke, P; ... ECLIPSE Investigators,; + view all (2011) Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med , 365 (13) 1184 - 1192. 10.1056/NEJMoa1105482.

Vichinsky, E; Bernaudin, F; Forni, GL; Gardner, R; Hassell, K; Heeney, MM; ... Coates, T; + view all (2011) Long-term safety and efficacy of deferasirox (Exjade (R)) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease. BRIT J HAEMATOL , 154 (3) 387 - 397. 10.1111/j.1365-2141.2011.08720.x.

Vichinsky, EP; Ohene-Frempong, K; Thein, SL; Lobo, CLD; Inati, A; Thompson, AA; ... Marks, PW; + view all (2011) Transfusion and Chelation Practices in Sickle Cell Disease: A Regional Perspective. PEDIATR HEMAT ONCOL , 28 (2) 124 - 133. 10.3109/08880018.2010.505506.

Virgili, A; Koptyra, M; Dasgupta, Y; Glodkowska-Mrowka, E; Stoklosa, T; Nacheva, EP; Skorski, T; (2011) Imatinib Sensitivity in BCR-ABL1-Positive Chronic Myeloid Leukemia Cells Is Regulated by the Remaining Normal ABL1 Allele. CANCER RES , 71 (16) 5381 - 5386. 10.1158/0008-5472.CAN-11-0068.

Visone, R; Veronese, A; Rassenti, LZ; Balatti, V; Pearl, DK; Acunzo, M; ... Croce, CM; + view all (2011) miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. BLOOD , 118 (11) 3072 - 3079. 10.1182/blood-2011-01-333484.

Wan, ES; Cho, MH; Boutaoui, N; Klanderman, BJ; Sylvia, JS; Ziniti, JP; ... COPD Gene investigators,; + view all (2011) Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol , 45 (2) 304 - 310. 10.1165/rcmb.2010-0294OC.

Wan, SG; Taccioli, C; Jiang, YB; Chen, HP; Smalley, KJ; Huang, K; ... Fong, LYY; + view all (2011) Zinc deficiency activates S100A8 inflammation in the absence of COX-2 and promotes murine oral-esophageal tumor progression. INT J CANCER , 129 (2) 331 - 345. 10.1002/ijc.25688.

Wang, AT; Sengerova, B; Cattell, E; Inagawa, T; Hartley, JM; Kiakos, K; ... McHugh, PJ; + view all (2011) Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair. GENE DEV , 25 (17) 1859 - 1870. 10.1101/gad.15699211.

Ward, NJ; Buckley, SMK; Waddington, SN; VandenDriessche, T; Chuah, MKL; Nathwani, AC; ... McVey, JH; + view all (2011) Codon optimization of human factor VIII cDNAs leads to high-level expression. BLOOD , 117 (3) 798 - 807. 10.1182/blood-2010-05-282707.

Westbury, CB; Sahlberg, KK; Borresen-Dale, AL; Isacke, CM; Yarnold, JR; (2011) Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients. RADIAT ONCOL , 6 , Article 42. 10.1186/1748-717X-6-42. Gold open access

Westin, J; Hellstrand, K; Dhillon, AP; Lagging, M; DITTO-HCV Study Grp,; (2011) Are FoxP3+cells involved in hyporesponsiveness to interferon/ribavirin therapy in chronic hepatitis C? J VIRAL HEPATITIS , 18 (2) 149 - 151. 10.1111/j.1365-2893.2010.01277.x.

Wickremasinghe, RG; Prentice, AG; Steele, AJ; (2011) Aberrantly activated anti-apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets. BRIT J HAEMATOL , 153 (5) 545 - 556. 10.1111/j.1365-2141.2011.08676.x.

Wickremasinghe, RG; Prentice, AG; Steele, AJ; (2011) p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies. LEUKEMIA , 25 (9) 1400 - 1407. 10.1038/leu.2011.103.

Wilkerson, PM; Dedes, KJ; Wetterskog, D; Mackay, A; Lambros, MB; Mansour, M; ... Reis-Filho, JS; + view all (2011) Functional characterization of EMSY gene amplification in human cancers. J Pathol , 225 (1) 29 - 42. 10.1002/path.2944.


Wykosky, J; Fenton, T; Furnari, F; Cavenee, WK; (2011) Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations. Chin J Cancer , 30 (1) 5 - 12. Gold open access

Yi, JM; Dhir, M; Van Neste, L; Downing, SR; Jeschke, J; Glockner, SC; ... Ahuja, N; + view all (2011) Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer. CLIN CANCER RES , 17 (6) 1535 - 1545. 10.1158/1078-0432.CCR-10-2509.

Yogev, O; Lagos, D; (2011) Noncoding RNAs and cancer. Silence , 2 (1) 6 - ?. 10.1186/1758-907X-2-6. Gold open access

Yogev, O; Naamati, A; Pines, O; (2011) Fumarase: a paradigm of dual targeting and dual localized functions. FEBS J , 278 (22) 4230 - 4242. 10.1111/j.1742-4658.2011.08359.x.

Yogev, O; Pines, O; (2011) Dual targeting of mitochondrial proteins: Mechanism, regulation and function. BBA-BIOMEMBRANES , 1808 (3) 1012 - 1020. 10.1016/j.bbamem.2010.07.004.

Yong, MY; Gonzalez-Beltran, A; Begent, R; (2011) Establishing a knowledge trail from molecular experiments to clinical trials. NEW BIOTECHNOL , 28 (5) 464 - 480. 10.1016/j.nbt.2011.03.016.

Yusa, K; Rashid, ST; Strick-Marchand, H; Varela, I; Liu, PQ; Paschon, DE; ... Vallier, L; + view all (2011) Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature , 478 (7369) 391 - 394. 10.1038/nature10424.

Zhang, EZ; Povazay, B; Laufer, J; Alex, A; Hofer, B; Pedley, B; ... Drexler, W; + view all (2011) Multimodal photoacoustic and optical coherence tomography scanner using an all optical detection scheme for 3D morphological skin imaging. Biomed Opt Express , 2 (8) 2202 - 2215. 10.1364/BOE.2.002202.

Zhou, YP; Adolfs, Y; Pijnappel, WWMP; Fuller, SJ; Van der Schors, RC; Li, KW; ... Pasterkamp, RJ; + view all (2011) MICAL-1 Is a Negative Regulator of MST-NDR Kinase Signaling and Apoptosis. MOL CELL BIOL , 31 (17) 3603 - 3615. 10.1128/MCB.01389-10.



Zweifel, M; Jayson, GC; Reed, NS; Osborne, R; Hassan, B; Ledermann, J; ... Rustin, GJS; + view all (2011) Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer. ANN ONCOL , 22 (9) 2036 - 2041. 10.1093/annonc/mdq708.

Book chapter

Lemech, CR; Kristeleit, RS; Arkenau, HT; (2011) Novel Oncology Drug Development Strategies in the Era of Personalised Medicine. In: Kapetanovic, IM, (ed.) Drug Discovery and Development - Present and Future.

Proceedings paper

Ayto, RM; Reed, M; Baker, R; Steele, AJ; Wickremasinghe, RG; Mehta, AB; Hughes, DA; (2011) Gaucher derived mono-layers prime myeloma cells for survival against chemo-therapeutic agents. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 16 - 16).

Babu, B; Ramos, J; Liu, Y; Chavda, S; Tzou, S; Brockway, O; ... Lee, M; + view all (2011) Design, synthesis, and DNA binding selectivity and affinity studies of the tetraamide PhIPI and its diamino analog PhIP*I. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.

Bjedov, I; Partridge, L; (2011) A longer and healthier life with TOR down-regulation: genetics and drugs. In: BIOCHEMICAL SOCIETY TRANSACTIONS. (pp. 460 - 465). PORTLAND PRESS LTD

Calvert, AH; (2011) Synthetic lethality in cancer treatment: Current status of PARP inhibitors. In: ANNALS OF ONCOLOGY. (pp. 13 - 13). OXFORD UNIV PRESS

Chavda, S; Liu, Y; Babu, B; Davis, R; Sielaff, A; Ruprich, J; ... Lee, M; + view all (2011) Hx, a novel fluorescent, minor groove and sequence specific recognition element: Design, synthesis, and DNA binding properties of p-anisylbenzimidazole imidazole/pyrrole-containing polyamides. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.

Cook, G; Kirkland, K; Lee, J; Pearce, RM; Apperley, JF; Clark, RE; ... Marks, DI; + view all (2011) Allogeneic Stem Cell Transplantation Induces Long Term Survival in Pateitns with Advanced Chronic Myeloid Leukaemia: A Study of the British Society for Blood and Marrow Transplantation. In: BLOOD. (pp. 1764 - 1764).

Danovi, D; Folarin, A; Pollard, S; (2011) Live Image Based Screen on Glioblastoma Stem Cells. In: EUROPEAN JOURNAL OF CANCER. (pp. S171 - S171). ELSEVIER SCI LTD

Dudderidge, J; Vasdev, N; Wollenschlaeger, A; Okoturo, O; Kelly, J; Stoeber, K; (2011) Diagnosis of bladder cancer by combined detection of minichromosome maintenance 5 protein and NMP22 in urine. In: BJU INTERNATIONAL. (pp. 7 - 7). WILEY-BLACKWELL

Dudderidge, TJ; Beatty, J; Larkin, J; Gore, M; Christmas, TJ; (2011) Surgery for loco-regional recurrence after nephrectomy for renal cell carcinoma (RCC): outcomes after initial incomplete resection and implantational recurrences. In: BJU INTERNATIONAL. (pp. 42 - 42). WILEY-BLACKWELL

Dudderidge, TJ; Robertson, N; Lavan, L; Rashid, T; Hawizy, A; Ogden, CW; (2011) Robotic prostatectomy delivers excellent outcomes and short hospital stay. Access in the NHS should be expanded not limited due to consumable costs. In: BJU INTERNATIONAL. (pp. 34 - 35). WILEY-BLACKWELL

Enver, T; (2011) Gene Regulatory Networks Governing Hematopoietic Stem Cell Development and Identity. In: BLOOD. (pp. 1815 - 1815).

Farren, TW; Liu, F; Macey, MG; Jenner, M; Prentice, A; Nathwani, A; Agrawal, SG; (2011) CD160: a novel approach to minimal residual disease (MRD) assessment in chronic lymphocytic leukaemia (CLL). In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 72 - 72).

Flutter, B; Edwards, N; Zhang, L; Sivakumaran, S; Croft, M; Sykes, M; Chakraverty, R; (2011) Enforced Co-Stimulation and Co-Inhibitory Blockade Synergize to Enhance the Functions of Exhausted CTL. In: BLOOD. (pp. 833 - 834).

Flutter, BR; Edwards, N; Zhang, L; Sivakumaran, S; Croft, M; Sykes, M; Chakraverty, R; (2011) Enforced co-stimulation and co-inhibitory blockade synergise to enhance the functions of exhausted CTL. In: IMMUNOLOGY. (pp. 38 - 38).

Galavotti, S; Shaked-Rabi, M; Tulchinsky, E; Brandner, S; Jones, C; Salomoni, P; (2011) THE METABOLIC AUTOPHAGY PATHWAY REGULATES MIGRATION AND INVASION IN GLIOMA. In: NEURO-ONCOLOGY. (pp. 10 - 10). OXFORD UNIV PRESS INC

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of a new automated thrombin generation assay that is sensitive to activated protein C resistance. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 3 - 3).

Hagerstrom, MN; Rorby, E; May, G; Tipping, A; Brown, J; Karlsson, G; ... Karlsson, S; + view all (2011) Gata2 Is a Direct Target for Smad-Mediated TGF beta Signaling in Hematopoietic Stem/Progenitor Cells. In: BLOOD. (pp. 580 - 580).

Hartig, N; Munoz-Alegre, M; Young, L; Rodriguez-Viciana, P; (2011) Role of R-Ras GTPases in the Wnt-Planar Cell Polarity pathway. In: MOLECULAR BIOLOGY OF THE CELL.


Hillmen, P; Gribben, JG; Follows, GA; Milligan, D; Sayala, HA; Moreton, P; ... Sub-Grp, NCRICLL; + view all (2011) Final response assessment of the CLL208 trial: an open-label phase II study to investigate the safety and efficacy of rituximab plus chlorambucil in previously untreated patients with CD20-positive B-cell chronic lymphocytic leukaemia (CLL). In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 21 - 21).


Kallinikou, K; Anjos-Afonso, F; Blundell, MP; Ings, SJ; Kassen, D; Thrasher, AJ; ... Yong, K; + view all (2011) CD26 Inhibition Can Aid the Homing of Cytokine Activated Mobilized Peripheral Blood (MPB)CD34+Cells to the Bone Marrow (BM) but a Ligand Dependent Attachment Defect Prevents Their Long Term Retention and Subsequent Engraftment. In: BLOOD. (pp. 68 - 68).

Kanga, U; McWhinnie, A; Mourya, MK; Sharma, R; Shaw, BE; Madrigal, A; Mehra, NK; (2011) HLA-DPB1 POLYMORPHISM IN NORTH INDIAN POPULATION. In: HUMAN IMMUNOLOGY. (pp. S137 - S137). ELSEVIER SCIENCE INC

Kassen, D; Rabin, N; Lath, D; Croucher, P; Yong, K; (2011) Deregulation of the bone marrow stromal compartment occurs early in multiple myeloma and precedes osteolytic bone disease. In: BONE. (pp. S253 - S254). ELSEVIER SCIENCE INC

Kassen, D; Rabin, N; Lath, D; Croucher, PI; Yong, K; (2011) Mechanisms of osteoblast supression in multiple myeolma. In: BONE. (pp. S37 - S37). ELSEVIER SCIENCE INC

Kottaridis, P; Tsirogianni, M; North, J; Marden, C; Mackinnon, S; Lowdell, MW; (2011) Results of a Phase 1 Clinical Trial of Allogeneic Tumor-Primed Natural Killer Cells in AML. In: BLOOD. (pp. 431 - 431).

Kuter, DJ; Mehta, A; Hollak, C; Giraldo, P; Hughes, D; Belmatoug, N; ... Zimran, A; + view all (2011) Miglustat Therapy in Type 1 Gaucher Disease: Long-Term Treatment Experience From a Multicenter, Retrospective Cohort Study. In: BLOOD. (pp. 1385 - 1385).

Lotta, LA; Wu, HM; Scully, MA; Noris, M; Veyradier, A; Mackie, IJ; ... Peyvandi, F; + view all (2011) Residual Plasmatic Activity of ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura Correlates with Disease Phenotype. In: BLOOD. (pp. 966 - 966).

Luc, S; Macaulay, IC; Buza-Vidas, N; Bouriez-Jones, T; Lutteropp, M; Woll, P; ... Jacobsen, SEW; + view all (2011) The Earliest Thymic T Cell Progenitors Sustain B Cell and Myeloid Lineage Potentials. In: BLOOD. (pp. 1011 - 1011).

Maramba, A; North, J; Lowdell, MW; Donaldson, C; (2011) IgM ligation triggers Zeta associated protein of 70 kDa (ZAP-70) tyrosine 292 and 319 phosphorylation in B-Chronic lymphocytic leukaemia (B-CLL). In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 72 - 73).

McDonald, V; Machin, SJ; Mackie, IJ; Scully, MA; (2011) The Prognostic Effects of Anti-ADAMTS13 IgG, IgA and IgM Antibody Subclasses In Acute Idiopathic TTP and the Effect of Rituximab. In: BLOOD. (pp. 1421 - 1421).


Morris, H; Morgan, MD; Woods, A; Ekeowa, UI; Butherus, K; Holle, JU; ... Harper, L; + view all (2011) ANCA-AAV, polymers and carriage of the Z allele of alpha 1AT. In: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. (pp. 75 - 76).

Nathwani, AC; Tuddenham, EGD; Rosales, C; Macintosh, J; Chowdary, P; Riddell, A; ... Davidoff, AM; + view all (2011) A phase i/ii clinical trial entailing peripheral vein administration of a novel self complementary adeno-associated viral vector encoding human fix for haemophilia b gene therapy. In: HUMAN GENE THERAPY. (pp. A7 - A8). MARY ANN LIEBERT INC

Peggs, K; (2011) The role of alemtuzumab in allogeneic stem cell transplantation. In: IMMUNOLOGY. (pp. 19 - 19).

Perera, G; Ainali, C; Barinaga, G; Williams, A; Mirza, M; Kassen, D; ... Nestle, F; + view all (2011) Systems analysis of psoriasis reveals a dominant IL-22 signature and IL-22 as non redundant checkpoint in psoriatic inflammation. In: JOURNAL OF INVESTIGATIVE DERMATOLOGY. (pp. S89 - S89). NATURE PUBLISHING GROUP

Perera, GK; Williams, A; Barinaga, G; Kassen, D; Barker, J; Ouyang, W; Nestle, FO; (2011) IL-22 is a potential therapeutic target in psoriasis. In: BRITISH JOURNAL OF DERMATOLOGY. (pp. 905 - 906). WILEY-BLACKWELL

Pfeifer, H; Cazzaniga, G; Spinelli, O; Cayuela, J-M; Cave, H; Vandenberghe, P; ... Ottmann, OG; + view all (2011) International Standardization of Minimal Residual Disease Assessment for in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Expressing m-BCR-ABL Transcripts: Updated Results of Quality Control Procedures by the EWALL and ESG-MRD-ALL Consortia. In: BLOOD. (pp. 1087 - 1087).

Pillay, N; Fernanda, MF; Berisha, F; Tirabosco, R; Flanagan, AM; (2011) P63 Does Not Regulate Brachyury in Chordomas and Osteosarcomas. In: JOURNAL OF PATHOLOGY. (pp. S24 - S24). WILEY-BLACKWELL

Popat, R; Dickson, J; Khan, I; Cheesman, S; Percy, L; Moore, S; ... Yong, K; + view all (2011) An Alternate Day Dosing Strategy for Lenalidomide in Multiple Myeloma Improves Cost-Effectiveness Whilst Maintaining Efficacy. In: BLOOD. (pp. 1797 - 1797).

Raj, D; Peggs, K; Pule, M; Linch, D; Davies, M; Nathwani, A; (2011) Adoptive immunotherapy for patients with chronic lymphocytic leukaemia using a chimeric antigen receptor targeting CD23. In: HUMAN GENE THERAPY. (pp. A120 - A121). MARY ANN LIEBERT INC

Rashid, ST; Yusa, K; Strick-Marchand, H; Rouhani, F; Miranda, E; Hannan, NR; ... Vallier, L; + view all (2011) TOWARDS CELL BASED THERAPY FOR alpha 1-ANTITRYPSIN DEFICIENCY THROUGH TARGETED BI-ALLELIC GENE CORRECTION IN HUMAN IPS CELLS. In: HEPATOLOGY. (pp. 421A - 421A).

Rashid, TG; Smith, TB; Prasad, AK; Dudderidge, TJ; Christmas, TJ; (2011) Eponymous Anonymous: the men behind the names. In: BJU INTERNATIONAL. (pp. 65 - 65). WILEY-BLACKWELL


Simmonds, N; Bates, AW; (2011) Reporting Paneth Cell Metaplasia in Paediatric GI Biopsies: An Audit on Current Practice and Review of Guidelines. In: JOURNAL OF PATHOLOGY. (pp. S19 - S19). WILEY-BLACKWELL

Steele, AJ; Prentice, AG; Last, V; Hoffbrand, AV; Wickremasinghe, RG; (2011) The p90RSK Inhibitor BI-D1870 Induces Apoptosis in CLL Cells. In: BLOOD. (pp. 1067 - 1067).

Tavarozzi, F; Mayor, NP; Cooke, L; Madrigal, JA; Marsh, SGE; Shaw, BE; (2011) Impact of HLA-DPA1 matching status on outcome, following unrelated donor hematopoietic stem cell transplantation, in the context of a 10/10 HLA-matched background. In: TISSUE ANTIGENS. (pp. 381 - 381). WILEY-BLACKWELL

Thirlwell, C; Schulz, L; Eymard, M; Luong, TV; Meyer, T; Davidson, B; ... Beck, S; + view all (2011) Integrated Genome-Wide DNA Methylation and mRNA Expression Analysis of Pancreatic NETs Identifies Differential Activation of the Hypoxia Inducible Factor (HIF) Pathway between Low and Intermediate Grade Tumors. In: NEUROENDOCRINOLOGY. (pp. 12 - 13).

Thomas, MR; Machin, SJ; Mackie, I; Scully, MA; (2011) B cell-activating factor (BAFF) is elevated in acute idiopathic thrombotic thrombocytopenic purpura (TTP). In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 8 - 8).

Tsogka, E; Brazma, D; Howard-Reeves, J; Grace, C; Nacheva, EP; (2011) MOLECULAR Karyotyping In CLL - COST Neutral Alternative to FISH SCREENING for Detection of Clinically Relevant Genome Imbalances. In: BLOOD. (pp. 1520 - 1520).

Tulpule, S; Russell, NH; Byrne, J; Das-Gupta, EP; Ethell, ME; Figueroa, D; ... Shaw, BE; + view all (2011) High Absolute T Regulatory Cell Counts and Resistance of CD8 Central Memory Cells to Killing by Fludarabine Predicts for Poor Responses to DLI in the Context of a Pre-DLI Lymphoreduction, Strategy. In: BLOOD. (pp. 834 - 834).

Virgilio, M; Payne, E; Narla, A; Sun, H; Paw, BH; Look, T; ... Khanna-Gupta, A; + view all (2011) L-Leucine Improves the Anemia of the 5q-Syndrome Via Activation of the mTOR (mammalian target of rapamycin) Pathway. In: BLOOD. (pp. 443 - 444).

Weinreb, N; Belmatoug, N; Bembi, B; Bodamer, O; Cappellini, MD; Deegan, PB; ... Therapeutic Goals MAP Taskforce,; + view all (2011) A novel tool for mapping disease severity and outcomes in patients with Gaucher disease utilising the therapeutic goals. In: MOLECULAR GENETICS AND METABOLISM. (pp. S46 - S46). ACADEMIC PRESS INC ELSEVIER SCIENCE

Whitmore, C; Ackroyd, MR; Ashraf, A; Alyoshkin, B; Muntoni, F; Brown, SC; (2011) Generation of a new mouse model for therapeutic testing in the dystroglycanopathies. In: NEUROMUSCULAR DISORDERS. (pp. 664 - 664). PERGAMON-ELSEVIER SCIENCE LTD

Whitmore, C; Ackroyd, MR; Ashraf, A; Brown, SC; (2011) Deposition of the inner limiting membrane in the eye of a mouse model for Muscle Eye Brain disease. In: NEUROMUSCULAR DISORDERS. (pp. 665 - 665). PERGAMON-ELSEVIER SCIENCE LTD

Whitmore, C; Ackroyd, MR; Ashraf, A; Brown, SC; (2011) Deposition of the inner limiting membrane in the eye of a mouse model for Muscle Eye Brain disease. In: NEUROMUSCULAR DISORDERS. (pp. S11 - S11). PERGAMON-ELSEVIER SCIENCE LTD

Whitmore, C; Ackroyd, MR; Ashraf, A; Muntoni, F; Brown, SC; (2011) Generation of a new mouse model for therapeutic testing in the dystroglycanopathies. In: NEUROMUSCULAR DISORDERS. (pp. S10 - S10). PERGAMON-ELSEVIER SCIENCE LTD

Whitmore, C; Ackroyd, MR; Muses, S; Ashraf, A; Muntoni, F; Brown, SC; Wells, DJ; (2011) Assessing the therapeutic potential of LARGE in a new mouse model of dystroglycanopathy. In: NEUROMUSCULAR DISORDERS. (pp. 665 - 665). PERGAMON-ELSEVIER SCIENCE LTD

This list was generated on Sat Jan 24 11:41:16 2015 GMT.